381 related articles for article (PubMed ID: 36547676)
1. Development and validation of a [
Li M; Yao H; Zhang P; Zhang L; Liu W; Jiang Z; Li W; Zhao S; Wang K
Eur Radiol; 2023 May; 33(5):3354-3365. PubMed ID: 36547676
[TBL] [Abstract][Full Text] [Related]
2.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract][Full Text] [Related]
3. An
Feng L; Lu X; Yang X; Kan Y; Sun D; Wang W; Yang J
Eur J Radiol; 2022 Sep; 154():110444. PubMed ID: 35917754
[TBL] [Abstract][Full Text] [Related]
4. Radiomics signature from [
Jiang C; Huang X; Li A; Teng Y; Ding C; Chen J; Xu J; Zhou Z
Eur Radiol; 2022 Aug; 32(8):5730-5741. PubMed ID: 35298676
[TBL] [Abstract][Full Text] [Related]
5. Radiomics-clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma.
Ding J; Li Z; Lin Y; Huang C; Chen J; Hong J; Fei Z; Zhou Q; Chen C
Sci Rep; 2023 Oct; 13(1):18167. PubMed ID: 37875498
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a
Liu H; Cui Y; Chang C; Zhou Z; Zhang Y; Ma C; Yin Y; Wang R
BMC Cancer; 2024 Jan; 24(1):150. PubMed ID: 38291351
[TBL] [Abstract][Full Text] [Related]
7. Development of a radiomic-clinical nomogram for prediction of survival in patients with diffuse large B-cell lymphoma treated with chimeric antigen receptor T cells.
Zhou Y; Zhang B; Han J; Dai N; Jia T; Huang H; Deng S; Sang S
J Cancer Res Clin Oncol; 2023 Oct; 149(13):11549-11560. PubMed ID: 37395846
[TBL] [Abstract][Full Text] [Related]
8. The value of
Ma J; Guo D; Miao W; Wang Y; Yan L; Wu F; Zhang C; Zhang R; Zuo P; Yang G; Wang Z
Abdom Radiol (NY); 2022 Apr; 47(4):1244-1254. PubMed ID: 35218381
[TBL] [Abstract][Full Text] [Related]
9. A novel analytic approach for outcome prediction in diffuse large B-cell lymphoma by [
Zhang X; Chen L; Jiang H; He X; Feng L; Ni M; Ma M; Wang J; Zhang T; Wu S; Zhou R; Jin C; Zhang K; Qian W; Chen Z; Zhuo C; Zhang H; Tian M
Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1298-1310. PubMed ID: 34651227
[TBL] [Abstract][Full Text] [Related]
10. Generation and validation of a PET radiomics model that predicts survival in diffuse large B cell lymphoma treated with R-CHOP14: A SAKK 38/07 trial post-hoc analysis.
Ceriani L; Milan L; Cascione L; Gritti G; Dalmasso F; Esposito F; Pirosa MC; Schär S; Bruno A; Dirnhofer S; Giovanella L; Hayoz S; Mamot C; Rambaldi A; Chauvie S; Zucca E
Hematol Oncol; 2022 Feb; 40(1):11-21. PubMed ID: 34714558
[TBL] [Abstract][Full Text] [Related]
11. Nomograms based on SUVmax of
Li H; Shao G; Zhang Y; Chen X; Du C; Wang K; Gao Z
Cancer Imaging; 2021 Jan; 21(1):9. PubMed ID: 33419476
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Value of
Feng L; Yang X; Lu X; Kan Y; Wang C; Zhang H; Wang W; Yang J
Acad Radiol; 2023 May; 30(5):940-951. PubMed ID: 36117128
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of the peripheral blood lymphocyte/monocyte ratio combined with
Wu W; Zhao L; Wang Y; Chen P; Yuan X; Miao L; Zhu Y; Mao J; Cai Z; Ji Y; Wang L; Jia T
Curr Probl Cancer; 2024 Feb; 48():101066. PubMed ID: 38364336
[TBL] [Abstract][Full Text] [Related]
14. A nomogram for predicting the rapid progression of diffuse large B-cell lymphoma established by combining baseline PET/CT total metabolic tumor volume, lesion diffusion, and TP53 mutations.
Liu C; Shi P; Li Z; Li B; Li Z
Cancer Med; 2023 Aug; 12(16):16734-16743. PubMed ID: 37366281
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Value of
Carlier T; Frécon G; Mateus D; Rizkallah M; Kraeber-Bodéré F; Kanoun S; Blanc-Durand P; Itti E; Le Gouill S; Casasnovas RO; Bodet-Milin C; Bailly C
J Nucl Med; 2024 Jan; 65(1):156-162. PubMed ID: 37945379
[TBL] [Abstract][Full Text] [Related]
16.
Xu X; Sun X; Ma L; Zhang H; Ji W; Xia X; Lan X
Front Oncol; 2023; 13():1149791. PubMed ID: 36969043
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of
Song Y; Tian Y; Lu X; Chen G; Lv X
Med Phys; 2024 Jan; ():. PubMed ID: 38252704
[TBL] [Abstract][Full Text] [Related]
18. Clinical parameters combined with radiomics features of PET/CT can predict recurrence in patients with high-risk pediatric neuroblastoma.
Feng L; Qian L; Yang S; Ren Q; Zhang S; Qin H; Wang W; Wang C; Zhang H; Yang J
BMC Med Imaging; 2022 May; 22(1):102. PubMed ID: 35643445
[TBL] [Abstract][Full Text] [Related]
19. Differentiation of early relapse and late relapse in intermediate- and high-risk neuroblastoma with an
Feng L; Yao X; Lu X; Wang C; Wang W; Yang J
Abdom Radiol (NY); 2024 Mar; 49(3):888-899. PubMed ID: 38315193
[TBL] [Abstract][Full Text] [Related]
20. [Based on CT radiomics model for predicting the response to first-line chemotherapy of diffuse large B-cell lymphoma].
Yin MX; Su QN; Song X; Zhang JX
Zhonghua Zhong Liu Za Zhi; 2023 May; 45(5):438-444. PubMed ID: 37188630
[No Abstract] [Full Text] [Related]
[Next] [New Search]
